520.09 USD
↗ 7.70 (1.50%)AT CLOSE (11:59 AM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
516.73
↘ 3.36 (0.65%)
POST MARKET (AS OF 05:45 PM EDT)
Post Market
AS OF 05:45 PM EDT
516.73
↘ 3.36 (0.65%)
Market: CLOSED
Open?$510.88
High?$524.31
Low?$508.52
Prev. Close?$512.39
Volume?216.0K
Avg. Volume?348.0K
VWAP?$518.77
Rel. Volume?0.62x
Bid / Ask
Bid?$508.49 × 40
Ask?$535.00 × 320
Spread?$26.51
Midpoint?$521.75
Valuation & Ratios
Market Cap?11.9B
Shares Out?22.9M
Float?16.4M
Float %?71.6%
P/E Ratio?N/A
P/B Ratio?19.80
EPS?-$12.57
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.00Strong
Quick Ratio?3.76Strong
Cash Ratio?0.64Adequate
Debt/Equity?0.56Moderate
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?19.80HIGH▾
P/S?12.45HIGH▾
P/FCF?N/A▾
EV/EBITDA?-40.4CHEAP▾
EV/Sales?12.60HIGH▾
Returns & Efficiency
ROE?-47.8%WEAK▾
ROA?-22.9%WEAK▾
Cash Flow & Enterprise
FCF?$-190020000
Enterprise Value?$12.1B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
11.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
200 BARR HARBOR DRIVE, SUITE 400
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263